Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.

Who May Be Eligible (Plain English)

Who May Qualify: - Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria); - Hoehn \& Yahr stage II-III (ON-medication state); - Able to walk independently for ≥5 minutes; - Stable medication for ≥1 month; - Currently enrolled in a rehab program at Ezra LeMarpe; - Able to provide written willing to sign a consent form; Who Should NOT Join This Trial: - Musculoskeletal, neurological, or visual/hearing impairments affecting gait; - Cognitive impairments or severe behavioral symptoms; - History of stroke, severe TBI, or brain tumor; - Cardiovascular contraindications; - Inability to use a smartphone; - Participation in other concurrent intervention studies. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria); * Hoehn \& Yahr stage II-III (ON-medication state); * Able to walk independently for ≥5 minutes; * Stable medication for ≥1 month; * Currently enrolled in a rehab program at Ezra LeMarpe; * Able to provide written informed consent; Exclusion Criteria: * Musculoskeletal, neurological, or visual/hearing impairments affecting gait; * Cognitive impairments or severe behavioral symptoms; * History of stroke, severe TBI, or brain tumor; * Cardiovascular contraindications; * Inability to use a smartphone; * Participation in other concurrent intervention studies.

Treatments Being Tested

BEHAVIORAL

Walking Tall App

Participants will use the Walking Tall smartphone app to complete 4-5 home-based walking sessions per week for 6 weeks. The app provides rhythmic auditory cues and verbal prompts to improve gait quality.

Locations (1)

Tel Aviv Sourasky Medical Center (Ichilov Hospital)
Tel Aviv, Israel